# Benefit-Risk Considerations for Product Quality Assessments - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/benefit-risk-considerations-for-product-quality-assessments/dd4547d7-4ac9-437a-8d9b-b88b234da4bc

> FDA guidance document: Benefit-Risk Considerations for Product Quality Assessments. Issue date: May 09, 2022. Get complete insights and analysis.

---

## Details

- Title: Benefit-Risk Considerations for Product Quality Assessments
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-05-09
- Comment Close Date: 2022-07-10
- Last Changed: 2022-05-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0168">FDA-2022-D-0168</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Quality Considerations for Topical Ophthalmic Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/quality-considerations-for-topical-ophthalmic-drug-products/19494a43-f26e-42c9-b1ad-99a1126b3d42)
- [How To Obtain a Covered Product Authorization](https://www.globalkeysolutions.net/guidances/guidance-document/how-to-obtain-a-covered-product-authorization/881f0322-95f9-4bfd-b6c3-35f5df950808)